This is the 32nd in a series of articles analyzing major companies by market capitalization traded on the tech-heavy Kosdaq market. — Ed Daehan New Pharm, a Seoul-based pharmaceutical and animal health product provider, will start selling an anti-cancer supplement next year, entering the market for the first time.
Day: December 19, 2016
Business | Smart Benefits: Cures Act Remedies A Small Business Condition
The 21st Century Cures Act, just signed into law by President Obama, is a broad health bill but tucked in it is a section that benefits small businesses by allowing them to use HRAs to reimburse employees who buy their own insurance. Starting January 1, an employer with fewer than 50 full-time employees can offer stand-alone HRAs and fund them by reimbursing employees for their premiums used to purchase individual health insurance.
Izzy Does It
Since July, Izzy Cox has battled pancreatic cancer. A staple in Austin clubs since migrating from Montreal this decade, the anarchist songbird’s presence has been sorely missed as she undergoes a wrath of surgeries and chemotherapy.
Today’s Events
Since July, Izzy Cox has battled pancreatic cancer. A staple in Austin clubs since migrating from Montreal this decade, the anarchist songbird’s presence has been sorely missed as she undergoes a wrath of surgeries and chemotherapy.
Achat Generique Artane a ” Livraison rapide
Ou ordonner Trihexyphenidyl a prix reduit. For decades, Generic Artane has been helping to alleviate pain caused by Parkinson’s disease.
BRIEF-JVM to buy back shares at 2 bln won
Gilead says Japan’s Ministry of Health, Labour and Welfare approves co’s Vemlidy for patients with chronic Hepatitis B virus infection * Gilead – Japan’s Ministry of Health, Labour and Welfare approves Gilead’s Vemlidy for patients with chronic Hepatitis B virus infection Source text for Eikon: Further company coverage:
View Press Release
A Once-Daily Treatment that Demonstrated Comparable Efficacy with Improved Renal and Bone Laboratory Safety Parameters Compared to Tenofovir Disoproxil Fumarate — )–Gilead Sciences, Inc. today announced that the Japanese Ministry of Health, Labour and Welfare has approved Vemlidy 25mg, a once-daily treatment for suppression of viral replication in chronic hepatitis B patients with evidence of hepatitis B virus replication and abnormal liver function. Vemlidy is a novel targeted prodrug of tenofovir that has demonstrated antiviral efficacy similar to and at a dose less than one-tenth that of tenofovir disoproxil fumarate 300mg.
Zsa Zsa Gabor had many things to say about her life in book
On life in Budapest: “The family led a life filled with grace and charm. There were vacations at our house on the shores of Lake Balaton, excursions in our Mercedes, parties glittering with beautiful women and dashing men, waltzing together under the flickering light of our crystal chandeliers.”
Zsa Zsa Gabor: A rare, unforgettable celebrity
Gabor died Sunday, Dec. 18, 2016, of a heart attack at her Bel-Air home, her husband, Prince Frederic von Anhalt, said. She was 99. .
Landmark Alzheimer’s prevention trial to evaluate third drug
An international team led by Washington University School of Medicine in St. Louis has selected a third investigational drug to be tested in a worldwide clinical trial – already underway – aimed at finding treatments to prevent Alzheimer’s disease. The third drug is being developed by Janssen Research & Development, LLC, in New Jersey.
Long-term anti-inflammatory drug use may increase cancer-related deaths for certain patients
… Felix, PhD, co-lead author of the study and cancer epidemiologist with the OSUCCC – James and College of Public Health. “These results are intriguing and worthy of further investigation,” says David Cohn, MD, gynecologic oncology division director …